Treatment with anti-CD40L at tumor implantation blocked the efficacy of radiation therapy combined with anti-CTLA4 in the CT26 tumor model (p < 0.01) (Fig. 3b) and the Panc02-SIY tumor model (p < 0.05) (Fig. 3c). This evidence concerns the gene CD40LG and neoplasm.